Internal Medicine, Critical Care Medicine · Detroit, MI
NPI
1619187572
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
4201 St. Antoine, Suite 4c
Detroit, MI, 48201
Phone (313) 745-4525
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
749 services
Medicare patients, 2024
309
Average age 74
Drug cost, 2024
$382K
987 prescriptions
Company payments, 2024
$141
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Najia Huda was code 99291 (critical care e&m), 146 times for 73 patients. In total Najia Huda billed 749 services in 26 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 146 | 73 | $172.09 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 111 | 73 | $94.14 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 94 | 62 | $63.01 | $5,923 |
| 99223 Hospital E&M - Initial | Facility | 54 | 54 | $138.37 | $7,472 |
| 94729 Pulmonary Function Testing | Facility | 46 | 42 | $6.34 | $292 |
| 99215 Office E&M - Established | Office | 39 | 32 | $109.56 | $4,273 |
| 94010 Pulmonary Function Testing | Facility | 37 | 35 | $5.92 | $219 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 24 | $13.12 | $407 |
| 99222 Hospital E&M - Initial | Facility | 29 | 29 | $104.97 | $3,044 |
| 99214 Office E&M - Established | Office | 28 | 26 | $77.16 | $2,160 |
| 94729 Pulmonary Function Testing | Office | 27 | 26 | $6.70 | $181 |
| 94010 Pulmonary Function Testing | Office | 23 | 22 | $5.98 | $138 |
| 99238 Hospital Discharge Management | Facility | 14 | 14 | $64.70 | $906 |
| 94060 Pulmonary Function Testing | Facility | 11 | 11 | $7.25 | $79.71 |
| 99205 Office E&M - New | Office | 11 | 11 | $146.16 | $1,608 |
By year: 2022 $85K for 812 services; 2023 $67K for 746 services; 2024 $65K for 749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Najia Huda prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 154 prescriptions and refills. In total Najia Huda wrote 987 Medicare prescriptions that cost $382K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 154 | 194 | 32 | $119K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 91 | 106 | 37 | $3,831 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 84 | 132 | 24 | $22K |
| Tiotropium Bromide Generic | 56 | 105 | 15 | $43K |
| Ventolin Hfa Albuterol Sulfate | 49 | 60 | 19 | $3,513 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 48 | 66 | 13 | $12K |
| Breo Ellipta Fluticasone/Vilanterol | 44 | 66 | 13 | $25K |
| Spiriva Respimat Tiotropium Bromide | 41 | 73 | 17 | $36K |
| Spiriva Handihaler Tiotropium Bromide | 38 | 80 | 12 | $37K |
| Fluticasone Propionate Generic | 35 | 62 | 19 | $624 |
| Montelukast Sodium Generic | 33 | 63 | Under 11 | $291 |
| Roflumilast Generic | 32 | 40 | Under 11 | $2,582 |
| Azelastine Hcl Generic | 31 | 48 | 17 | $805 |
| Symbicort Budesonide/Formoterol Fumarate | 24 | 38 | Under 11 | $8,246 |
| Prednisone Generic | 24 | 25 | 17 | $69.92 |
Brand drugs: 607 claims; generic drugs: 380 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Najia Huda $141 ($141 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $103.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.